Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermaglow is a commercial medical aesthetics device company focused on professional microdermabrasion systems for aestheticians, med spas, and skin care practices. The company markets U.S.-made microdermabrasion devices and related consumables, positioning itself as a long-standing supplier to the professional aesthetics market since 1998. Its product line includes the Dermaglow 3/3MD and Dermaglow EST systems, which are used for noninvasive skin resurfacing and rejuvenation procedures. Based on available public information, Dermaglow appears to be an operating healthcare-adjacent aesthetics company rather than a drug-development biotech or pharmaceutical developer. No evidence was found of a therapeutic pipeline, clinical-stage drug assets, or molecular targets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermaglow.